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It is axiomatic that the renin-aldosterone system and volume. In dogs, a reduction of blood volume infirst infusion period.
concentrations achieved were within the physioconcentration Of POsturd hypovolda has been *Own the higher rate of infusion, there was only a very to increase the plasma concentration or 'activity' of both renin (Conn, Rovner & Cohen, 1965; Brown, slight pressor response. significant fall of Davies, Lever, McPherson & Robertson, 1966 ) and plasma protein concentration and peripheral venous vasopressin
1968;
lg71; siamt change of Davies t Forsling, 1975) . These observations suggest endocrine systems which must be central to the plasma VoIume at the expense of the e x~m l a r M e b b i n , 1967; Vander, 1968; TagaWa, Vmder, Bonjour & Malvin, 1971) , even when the filtration function of the kidney is destroyed (Shade, Davis, Johnson, Gotshall & Spielman, 1973) . Conversely, it has been suggested that angiotensin infusions increase vasopressin secretion (Bonjour & Malvin, therefore set out to determine the effect of infusing arginine vasopressin in physiologically relevant amounts on plasma renin activity in man. We have also made measurements which indicate that the suppression of plasma renin activity which we have observed is due to the effect of vasopressin on the distribution of extracellular fluid between its intravascular and extravascular compartments.
Materials and methods

Subjects and experimental protocol
The studies were performed on twelve male volunteers, aged 19-23 years. They all took an unrestricted diet but ethanol and tobacco were disallowed for at least 12 h before the study began. On the morning of the study they ate a light breakfast with a glass of milk and then they rested, fully recumbent, for 2 h (from 07.00 to 09.00 hours). Small indwelling catheters (Butterfly R-19, Abbott Laboratories, Chicago, Ill., U.S.A.) were placed in both antecubital veins under local anaesthesia. Blood samples were collected from one of these catheters and the other catheter was used for infusion. After obtaining two control blood samples (at -10 and 0 rnin), glucose (50 g/l) was infused at 09.00 hours by an infusion pump (Palmer, England) at a constant rate of 0.8 ml/min for 240 min. Blood samples were collected at 15 rnin intervals between 09.00 and 10.00 hours (pre-infusion period, 0-60 min), 12.00 and 13.00 hours (recovery period, 180-240 min) and at 10 min intervals between 10.00 and 12.00 hours (vasopressin infusion period, 60-180 min). During the pre-infusion and recovery periods only glucose was infused and during the arginine vasopressin infusion period seven of the subjects were infused with synthetic arginine vasopressin at a constant rate of 123 munitslmin and 25 munitslmin for 60 min at each dose. Arginine vasopressin was standardized by pressor bioassay, with USP posterior lobe reference standard, and was estimated to contain 170 i.u./ml (Sigma Chemical Co., St Louis, Mo., U.S.A.). This solution was diluted with glucose (50 g/l) to obtain the required concentrations of arginine vasopressin for infusion. In order to provide a proper control for the study, five subjects were infused with glucose only throughout the study period. In these subjects the amount of blood removed and the frequency of sampling was identical with those who were infused with arginine vasopressin.
The effect of infusion on arterial blood pressure and heart rate was determined by infusing arginine vasopressin in six other male volunteers (aged 19-24 years) at the same rate (12.5 munits/min and 25 munitslmin) for 40 rnin at each dose. Blood pressure and heart rate were recorded every 10 min, but the slow glucose (50 g/l) infusion (0.8 ml/min) given in the main study was not used.
Collection of blood
Blood samples were collected into plastic syringes, transferred into heparinized polystyrene tubes, precooled to 4"C, and the plasma was separated immediately by centrifugation at 4°C. The plasma was then decanted into plastic tubes, 'snap-frozen' and stored at -20°C. All samples were analysed within 2 weeks of collection.
Analytical procedures
Arginine vasopressin was estimated, in 5-10 ml plasma samples, after adsorption on to glass beads and elution with aqueous acetone (Forsling, 1974) , in rats anaesthetized with ethanol (Forsling, Jones & Lee, 1968) . The design of the assay and the assessment of its error limits were carried out according to the description given by Errington & Rocha e Silva (1972) . Losses on storage and extraction were allowed for in each plasma sample, and the values reported have been corrected accordingly; overall losses for this study were 3 4 % f 7 (meanks~). A cautious assessment of the detection limit of the actual assay runs used in producing the values reported was 0.5 punitlml of plasma.
Plasma renin activity was determined by estimating the rate of generation of angiotensin I, which was measured in 1 ml of plasma by the precise radioimmunoassay technique of MBnard & Catt (1972) , with angiotensin I antibody kindly donated by Dr J. MCnard. Their method was modified only in that dimercaprol was omitted from the mixture of angiotensin inhibitors. A realistic estimate for the limit of detection was 0.1 pmol h-ml -l. The use of plasma renin activity to index changes of plasma renin concentration was validated by the addition of three increments of MRC Standard Human Renin (batch no. 68/356; Medical Research Council, Division of Biological Standards, National Institute for Medical Research, London) to plasma obtained from the same subject during pre-infusion, arginine vaso-pressin infusion and recovery periods, The rate of generation of angiotensin I (plasma renin activity) increased as a linear function of added renin. Thus the change of renin activity at the end of the first infusion period (from 1 *50 pmol h -ml -to 0.45 pmol h -ml -or -70%) was similar to the change of renin concentration [from 37.3 ,mnits/ml (Goldblatt) to 11.9 punitsid or -68x1, estimated by addition of exogenous human renin. These results indicate that the changes of plasma renin activity which we have observed in response to arginine vasopressin are not due to alterations of the activity of renin substrate nor to alterations of the activity of inhibitors or activators of the renin-substrate reaction.
In order to make sure that the preparation of vasopressin we used did not affect the kinetics of the reaction between endogenous renin and renin substrate, two aliquots of the same plasma sample, with and without a large quantity of added arginine vasopressin (200 wnitslmll, were assayed simultaneously. Plasma renin activity in both these samples was identical, i.e. 1.86 pmol h-l ml-1 without added arginine vasopressin and 1.90 pmol h -ml -with added arginine vasopressin. Peripheral venous packed cell volume (PCV) was estimated from the haemoglobin concentration and mean corpuscular volume (Coulter-S, model 1034, Coulter Electronics Ltd, U.K.) on pre-infusion blood samples and on the samples collected at the end of the second arginine vasopressin infusion period. The percentage change of plasma volume was calculated as described by Van Beaumont (1972) .
Mean arterial pressure was calculated from the sum of the diastolic pressure and one-third of the pulse pressure.
Calculation of results
The results are expressed either as absolute figures or as a percentage difference from the mean of the initial values for each individual. They are analysed by using paired or unpaired values by Student's t-test for sisnificance. Mean values with 1 SEM are given. 
Results
Effects of vasopressin infusion
Effect on plasma renin activity and plasma vasopressin concentration. In Fig. 1 the mean plasma renin activity and arginine vasopressin concentrations have been plotted against time. During the preinfusion period, when only glucose was infused, plasma renin activity and concentration of arginine vasopressin remained stable. Arginine vasopressin, infused at 125 munitslmin, lowered renin activity sharply and progressively in all the subjects : mean activity fell from 1.73 pmol h-l ml -l k0.10 to 0.92 pmol h -ml -f 0.08 or by 45 % (P < 0401) at the end of the first hour. The corresponding mean plasma arginine vasopressin rose from 1.61 ,uunits/ml& 0.21 to 9.71 bunits/ml41.42. Doubling the rate of infusion to 25 munitslmin lowered plasma renin activity further to a mean value of 059 pmol h -l m1-l f0.06 or by 65%, and the mean plasma arginine vasopressin concentration rose to 14-46 punits/ml f 3.64. The plasma arginine vasopressin concentrations achieved during the second infusion period varied (maximum coefficient of variation = 67%). In one subject the plasma concentration rose only from 1.1 to 8-4 punitslml, but, despite this moderate increase, the corresponding plasma renin activity fell from 1.65 pmol h -ml -to 0.37 pmol h-'rnl-' or 77%.
After termination of the infusion of arginine vasopressin (recovery period) plasma renin activity increased progressively in all subjects as the plasma arginine vasopressin concentration fell. At the end of the recovery period, the mean renin activity was 1.49 pmol h -ml -t 0.1, or very nearly the same as, but rather lower than, the mean pre-infusion value. However, the mean plasma arginine vasopressin concentration was also higher than the mean preinfusion value, at 3.17 punitslml f0.4.
Effect on p l a s m protein Concentration and plasma renin activity. The percentage change (from the mean pre-infusion value in each subject) in plasma protein concentration and renin activity in response to infusion of arginine vasopressin is shown in Fig. 2 . There was a progressive and highly significant (P c 0.001) decrease of plasma protein concentration, which appears to parallel the fall of plasma renin activity. The mean plasma protein concentration decreased by 4.7 % f 0.7 and 6.3 % + 0.8 at the end of the two infusion periods respectively. The corresponding mean fall of plasma renin activity was 47 % f 4.1 and 66xk2.8. During the recovery period the mean plasma protein concentration rose and at the end of 1 h it was 3-6%+1.1 below the mean preinfusion value, whereas renin activity was 15 % k2.4 below the mean pre-infusion value. The mean increase of plasma volume estimated from the change of peripheral venous PCV at the end of the second infusion period was 10.2% f 1.5. As the PCV values are not corrected for the amount of blood removed, the mean increase of plasma volume, so calculated, is overestimated as compared with the mean value estimated from the change of plasma protein concentration. Effect on plasma osmolality and plasma sodium concentration. Fig. 3 shows the percentage change of plasma osmolality and plasma sodium concentration plotted against time. There was no significant change either of plasma osmolality or plasma sodium concentration during infusion of vasopressin.
Eflect on heart rate and arterial bloodpressure. The response of the blood pressure and heart rate to infusion of arginine vasopressin is shown in Fig. 4 . The percentage change has been calculated from the mean pre-infusion values and is plotted against time.
The mean heart rate fell significantly (P ~0 . 0 5 , n = 6) from 68 beatslmin r 5.0 to 63 beatslmin f4.3 or 6% within 10 min of starting the infusion at 12.5 munitslmin. Slight but significant bradycardia was maintained throughout the study and doubling the rate of infusion to 25 munitslmin did not further lower the heart rate (62 beatsimin f 3.7 or a fall of 7% from the mean pre-infusion value). Although the mean arterial pressure did not change significantly, a moderate but significant (P<O-O25) increase was recorded in the mean diastolic blood pressure from 75 mmHg k2.2 to 79 mmHg k2.2 or 5% at the end of the higher rate of infusion. However, at the lower rate of infusion there was no signiscant change of blood pressure despite a significant fall of the mean heart rate. The systolic blood pressure did not change significantly throughout the study.
Effects of gIucose infusion
Efect on plasma protein concentration and plasma renin activity. The mean percentage change of plasma protein concentration and renin activity in the five subjects infused with glucose only is shown in Fig. 5 . There was no significant change either of the mean plasma protein concentration or the plasma renin activity throughout the experimental period. The mean plasma protein concentration changed by +0.3%+0.5 and -0-7%+1.1 at the end of the second and third hours, corresponding to the end of the lower and higher rates of arginine vasopressin infusion respectively. The corresponding change of plasma renin activity was -1.6% k0.6 and -1.2% k 1 .O from the mean pre-infusion values. In accordance with the lack of change in the plasma protein concentration, the mean percentage change of plasma volume (0-9 % f 14), estimated from the peripheral venous PCV at the end of the third hour, also did not change significantly. Thus in these studies there was no change of either the estimated mean plasma volume or of renin activity, despite the removal of the same amount of blood, as in the vasopressin infusion studies.
Efect on plasma sodium concentration and plasma osmolality. When glucose (50 gll) alone was infused, there was no significant change of plasma osmolality or plasma sodium concentration, nor was there any trend throughout the period of study, despite measurements being made every 10-15 min. The variation was less than 1 % throughout for both, well within the error of their respective estimations.
Discossion
Our results confirm the findings of animal experiments that plasma renin activity is reduced sharply by vasopressin infused at rates which have no effect on arterial pressure. We suggest that this indicates a reduction in the rate of renin release. This interpretation assumes first, that change8 of plasma renin activity parallel those of renin concentration and, secondly, that changes of renin concentration, under the conditions of our study, reflect the rate of renin release. We have wnfirmed that changes of plasma renin activity reflect those of renin concentration but it is more diflicult to exclude the possibility that changes of concentration may not reflect changes of renin secretion. The plasma concentrations of arginine vasopressin seen in this study (2.6-16.9 punitslml) are quite modest physiologically, although they are probably maximally antidiuretic. They are clearly within the range seen after surgical trauma (Moran, Miltenberger, Shu'ayb & Zimmermann, 1964 ; Moran & Zimmermann, 1967) as well as after a standardized 85" head-up tilt (Davies & Forsling, 1975 However, from an analysis of the changes of plasma protein concentration and haematocrit that we have observed, we suggest that arginine vasopressin, infused at a rate which has little cardiovascular effect, increases plasma volume at the expense of the extravascular fluid. Since the inverse relationship between plasma volume and renin secretion is well established, the increase of plasma volume which we have observed may well explain the fall of plasma renin activity.
This conclusion assumes that the changes of plasma protein concentration and the changes of PCV reflect changes of plasma volume during the period of the study. Both variables changed in the same direction, but the interpretation of the fall of PCV is complicated by the fact that about 190 ml of blood was removed during the course of the study. Adjusting for this, the PCV would still appear to have fallen in such a way as to imply an increase in plasma volume of about 200 ml. This observation, by its magnitude alone, can hardly be ascribed to sequestration of erythrocytes, although a small component may possibly be due to a change of small vesselllarge vessel PCV ratio (Chacalos, 1967) . It is also possible that arginine vasopressin, in amounts which do not change perfusion pressure, provokes a subtle increase in the rate of protein loss across capillaries. However, this would lead to an increase of peripheral PCV rather than the reduction we have observed. A significant increase of plasma volume when vasopressin is infused into trained conscious dogs for 1 h has been demonstrated by Szczepanska-Sadowska (1973) . The mean increase of plasma volume (estimated by dye-dilution technique) was 120 ml when the mean plasma vasopressin concentration was 22 punitslml, or similar to that which is observed after a non-hypotensive haemorrhage in the dog (Szczepanska-Sadowska, 1972) .
Our studies are short-term; in the longer term different results may be obtained. Goodwin, Ledingham & Laragh (1970) gave large amounts of vasopressin daily for 5 days to normal people and suggested that, when fluid intake was restricted, plasma renin activity did not change. However, although they claim that the changes of activity were 'unimpressive', two subjects did show a fall of renin activity and a rise of plasma volume. Indeed, Newsome & Bartter (1968) had already shown that chronic administration of vasopressin lowers plasma renin activity only when accompanied by an increase of plasma volume. Our results are consonant, but it is still possible that the changes of plasma volume and renin activity that we observed may not be causally related. The fall of plasma renin activity in our study is equivalent to that seen when sodium chloride (150 mmol/l) is infused into normal humans so as to produce a comparable increase of plasma volume in the same period of time (Tuck, Dluhy & Williams, 1974) . Thus even kinetic considerations are compatible with our hypothesis but the possibility that there is also a direct effect of arginine vasopressin on the juxtaglomerular apparatus, as has been suggested in animal studies, Cannot be excluded.
None the lsss, we suggest that the evidence best fits with the idea that, in man, physiologically relevant amounts of vasopressin suppress the rate of renin secretion indirectly by increasing plasma volume at the expense of the extravascular fluid.
